Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Cervical Cancer, Precancerous Condition

In brief

RATIONALE: Chemoprevention is the use of certain drugs to keep tumors from forming, growing, or coming back. Zoledronate may prevent the growth of cervical cancer by blocking blood flow to cervical intraepithelial neoplasia cells. The use of zoledronate may keep cancer from forming. PURPOSE: This randomized is studying how well zoledronate works in treating patients with cervical intraepithelial neoplasia 2/3 or 3.

Key facts

Study ID

NCT00278434

Run by

University of California, San Francisco

People needed

12

Starts

2005-04-01

Expected to finish

2008-07-01

Last updated by the study team

2017-11-24

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

Where it is running

• UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.